Department of General Surgery/Shanghai Clinical Nutrition Research Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Curr Opin Clin Nutr Metab Care. 2021 May 1;24(3):223-228. doi: 10.1097/MCO.0000000000000736.
Sarcopenia is prevalent in cancer patients and can occur as a result of cancer as well as cancer-related therapies. It is related to high postoperative complications, long hospitalization, slow recovery as well as low tolerance to chemotherapy. Patients with sarcopenia also have poor oncological outcomes. Oral nutritional supplements (ONS) and physical activity have shown great potentials in managing this debilitating condition. We summarized the recent developments in the assessment of sarcopenia and its management with ONS and physical activity.
Many methods were developed to evaluate sarcopenia including muscle quality/quantity measurement and functional tests. Recent studies have shown that ONS and physical training can be used in managing sarcopenia, especially when used together as part of a multimodal intervention. However, barriers such as low awareness and lack of training and support for both patients and healthcare workers still exist and need attention.
Recent findings highlighted the benefits of identifying sarcopenia and managing those at risk. The details of a multimodal protocol, such as components of nutritional substrates, the intensity of physical exercise, and the use of medication need to be further looked into for an optimum approach. Education and training programs need to be developed to overcome the barriers in managing sarcopenia.
肌肉减少症在癌症患者中很常见,可由癌症本身或癌症相关治疗引起。它与术后并发症高、住院时间长、恢复缓慢以及对化疗的耐受性低有关。患有肌肉减少症的患者预后也较差。口服营养补充剂(ONS)和身体活动在治疗这种使人衰弱的疾病方面显示出巨大的潜力。我们总结了肌肉减少症评估及其管理的最新进展,包括 ONS 和身体活动。
已经开发出许多方法来评估肌肉减少症,包括肌肉质量/数量的测量和功能测试。最近的研究表明,ONS 和体育锻炼可用于治疗肌肉减少症,尤其是当它们作为多模式干预的一部分联合使用时。然而,患者和医护人员对其认识不足、缺乏培训和支持等障碍仍然存在,需要引起重视。
最近的研究结果强调了识别肌肉减少症并对其高危人群进行管理的重要性。需要进一步研究多模式方案的细节,例如营养底物的组成、身体活动的强度以及药物的使用,以找到最佳的治疗方法。需要制定教育和培训计划来克服管理肌肉减少症的障碍。